Key result
Hypertensive disorders of pregnancy show no significant link to subfoveal choroidal thickness changes.
Why the study?
The study aimed to evaluate subfoveal choroidal thickness in women with uncomplicated pregnancy and hypertensive disorders of pregnancy and assess postpartum changes.
Does subfoveal choroidal thickness differ between women with hypertensive disorders of pregnancy and those with uncomplicated pregnancies?
Cross-Sectional (n=48)
No
Does subfoveal choroidal thickness differ between women with hypertensive disorders of pregnancy and those with uncomplicated pregnancies?
Subfoveal choroidal thickness shows non-significant trends toward being lower in hypertensive disorders of pregnancy compared to uncomplicated pregnancies, suggesting potential as a non-invasive biomarker for systemic vascular dysregulation.
Answers are grounded in this paper and cite their sources.
No significant difference observed; leaves open choroidal thickness as potential biomarker pending prospective studies.
Purpose This study aimed to evaluate subfoveal choroidal thickness (SFCT) in women with uncomplicated pregnancy and those with hypertensive disorders of pregnancy (HDP), using spectral-domain optical coherence tomography (SD-OCT), and to assess changes in SFCT during the postpartum period. Methods The study was jointly carried out in the Departments of Ophthalmology and Obstetrics & Gynaecology at All India Institute of Medical Sciences, Bhopal, a tertiary care referral centre in central India, over a period of 18 months, from March 2021 to September 2022. A hospital-based cross-sectional study was conducted on pregnant women in their third trimester, including those with HDP and those with uncomplicated pregnancies. All participants underwent routine antenatal work-up, comprehensive ocular examination, and enhanced depth imaging optical coherence tomography (EDI-OCT) to measure SFCT. Follow-up assessments were performed at six weeks postpartum to evaluate postnatal changes in choroidal thickness. Results A total of 96 eyes from 48 pregnant women were evaluated. An overall increase in SFCT was observed in the postpartum period; however, this increase was not statistically significant, possibly due to the small sample size and loss to follow-up postpartum. In addition, the mean SFCT was higher in the uncomplicated pregnancy group compared to those with HDP, although this difference was also statistically insignificant. Despite limited statistical power, these findings suggest that HDP may influence choroidal thickness differently compared to normotensive pregnancies. Conclusion This study highlights the potential role of SFCT as a non-invasive biomarker for early identification and risk stratification of hypertensive disorders in pregnancy. Although the results did not reach statistical significance, the observed trends support the hypothesis that choroidal vascular changes may reflect underlying systemic vascular dysregulation in HDP. Future research with larger sample sizes and longer follow-up is warranted to validate these findings and to explore the utility of mean-adjusted choroidal thickness as a predictive marker for HDP severity and progression.
No takes yet. Share an insight, caveat, or question.
Nyodu et al. (2025) conducted a cross-sectional in Hypertensive disorders of pregnancy (n=48). Hypertensive disorders of pregnancy vs. Uncomplicated pregnancy was evaluated on Antenatal subfoveal choroidal thickness (right eye, µm) (p=0.25). Hypertensive disorders of pregnancy were not associated with a significant difference in subfoveal choroidal thickness compared to uncomplicated pregnancies.
Synapse has enriched 10 related papers. Consider them for comparative context: